Abstract
Introduction: Breast cancer is rapidly emerging as the leading cause of cancer in Indian women. Robust cytopathology and histopathology services are required to tackle this growing burden. The use of rapid on-site evaluation (ROSE) and the International Academy of Cytology (IAC) Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy (FNAB) Cytopathology, which offers structured protocols, are expected to improve breast cytopathology reporting. Methods: We retrieved the cytopathology slides, categorized them by the IAC Yokohama System and histopathology data of all the patients who had been investigated for breast lesions from September 2016 to December 2018, and compared the cytopathology and histopathology. Risk of malignancy (ROM) and performance metrics, like sensitivity, specificity, predictive values, accuracy, and area under the curve were computed. Results: A total of 1,147 FNABs were evaluated, of which 442 (38.5%) underwent ROSE and 624 (54.4%) histopathology. Reported using IAC categories, our cohort recorded 4.9% inadequate, 65.3% benign, 7.8% atypical, 3.3% suspicious for malignancy, and 18.7% malignant lesions. The overall sensitivity and specificity for identifying in situ and malignant lesions were 99.1% and 99.3%, respectively, and were substantially improved by ROSE. ROSE improved the concordance between cytopathology and histopathology from 76.9% to 90.2%, by reducing inadequate (p < 0.001) cases. The ROM increased along a gradient from inadequate to malignant categories, with the gradient being sharpened by ROSE. The false negativity rate was 0.7% and false positivity rate 0%. Conclusion: Incorporating ROSE and the IAC Yokohama System for breast cytopathology reporting improves accurate diagnosis of breast lesions, prevents missed diagnoses, and provides reliable estimates of ROM. These protocols also aid in standardizing a reproducible system for monitoring and auditing of breast pathology services, identify areas that need strengthening, and improve training at pathology centers.
References
1.
Field
AS
. Breast FNA biopsy cytology: current problems and the International Academy of Cytology Yokohama standardized reporting system
. Cancer Cytopathol
. 2017
;125
(4
):229
–30
.2.
Singh
N
, Wells
CA
. Assessment of accuracy in breast cytology
. Cytopathology
. 2001
;12
(4
):211
–8
.3.
Field
AS
, Raymond
WA
, Schmitt
F
, editors. The International Academy of Cytology Yokohama system for reporting breast fine needle aspiration biopsy cytopathology
. Switzerland
: Spinger Nature
; 2020
.4.
Panwar
H
, Ingle
P
, Santosh
T
, Singh
V
, Bugalia
A
, Hussain
N
. FNAC of breast lesions with special reference to IAC standardized reporting and comparative study of cytohistological grading of breast carcinoma
. J Cytol
. 2020
;37
(1
):34
–9
.5.
Mathur
P
, Sathishkumar
K
, Chaturvedi
M
, Das
P
, Sudarshan
KL
, Santhappan
S
; ICMR-NCDIR-NCRP Investigator Group
, . Cancer statistics, 2020: report from National Cancer Registry Programme, India
. JCO Glob Oncol
. 2020
;6
:1063
–75
.6.
Globocan 2018: India factsheet – India Against Cancer. Available from: cancerindia.org.in.
7.
Montezuma
D
, Malheiros
D
, Schmitt
FC
. Breast Fine needle aspiration biopsy cytology using the newly proposed IAC Yokohama system for reporting breast cytopathology: the experience of a single institution
. Acta Cytol
. 2019
;63
:1
–6
.8.
Kothari
K
, Tummidi
S
, Agnihotri
M
, Sathe
P
, Naik
L
. This ‘rose’ has no thorns-diagnostic utility of ‘rapid on-site evaluation’ (rose) in fine needle aspiration cytology
. Indian J Surg Oncol
. 2019
;10
(4
):688
–98
.9.
Wong
S
, Rickard
M
, Earls
P
, Arnold
L
, Bako
B
, Field
AS
. The International Academy of Cytology Yokohama System for reporting breast fine needle aspiration biopsy cytopathology: a single institutional retrospective study of the application of the system categories and the impact of rapid onsite evaluation
. Acta Cytol
. 2019
;63
(4
):280
–91
.10.
Tummidi
S
, Kothari
K
, Agnihotri
M
, Nail
L
, Sood
P
. Fibroadenoma versus phyllodes tumor: a vexing problem revisited
. BMC Cancer
. 2020
;20
(1
):648
–60
.11.
Colditz
G
, Chia
KS
. Invasive breast carcinoma: introduction and general features
. In: Lakhani
SR
, Ellis
IO
, Schnitt
SJ
, Tan
PH
, van de Vijver
MH
, editors. WHO classification of tumours of the breast
. 4th ed. Lyon
: IARC
. p. 14
–31
.13.
Gupta
S
. Breast cancer: Indian experience, data, and evidence
. South Asian J Cancer
. 2016
;5
(3
):85
–6
.14.
Malvia
S
, Bagadi
SA
, Dubey
US
, Saxena
S
. Epidemiology of breast cancer in Indian women
. Asia Pac J Clin Oncol
. 2017
;13
(4
):289
–95
.15.
Arul
P
, Masilamani
S
. Application of National Cancer Institute recommended terminology in breast cytology
. J Cancer Res Ther
. 2017
;13
(1
):91
–6
.16.
Chakrabarti
I
. FNAC versus CNB: who wins the match in breast lesions
. J Cytol
. 2018 JulSep
;35
(3
):176
–8
.17.
Kamatar
PV
, Athanikar
VS
, Dinesh
U
. Breast fine needle aspiration biopsy cytology reporting using international academy of cytology yokohama system-two year retrospective study in tertiary care centre in Southern India
. Njlm
. 2019
;8
(4
):PO01
–3
.18.
Saha
A
, Mukhopadhyay
M
, Das
C
, Sarkar
K
, Saha
AK
, Sarkar
DK
. FNAC versus core needle biopsy: a comparative study in evaluation of palpable breast lump
. J Clin Diagn Res
. 2016
;10
(2
):EC05
–8
.19.
Mitra
S
, Dey
P
. Fine-needle aspiration and core biopsy in the diagnosis of breast lesions: a comparison and review of the literature
. Cytojournal
. 2016
;13
:18
.20.
Moschetta
M
, Telegrafo
M
, Carluccio
DA
, Jablonska
JP
, Rella
L
, Serio
G
, . Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesions
. G Chir
. 2014
;35
(7–8
):171
–6
.21.
Tikku
G
, Umap
P
. Comparative study of core needle biopsy and fine needle aspiration cytology in palpable breast lumps: scenario in developing nations
. Turk Patoloji Derg
. 2016
;32
(1
):1
–7
.22.
Mitra
SK
, Rajesh
R
, Mishra
RK
, Rai
P
, Vahikar
S
, Singhal
P
. Comparative evaluation of FNAC, core needle biopsy and excisional biopsy in subtyping of breast lesions
. J Path Micro
. 2016
;2
(1
):9
–15
.23.
Joshi
M
, Reddy
SJ
, Nanavidekar
M
, Russo
JP
, Russo
AV
, Pathak
R
. Core biopsies of the breast: diagnostic pitfalls
. Indian J Pathol Microbiol
. 2011
;54
(4
):671
–82
.24.
Nassar
A
. Core needle biopsy versus fine needle aspiration biopsy in breast: a historical perspective and opportunities in the modern era
. Diagn Cytopathol
. 2011
;39
(5
):380
–8
.25.
Ljung
BM
, Drejet
A
, Chiampi
N
, Jeffrey
J
, Goodson
WH
3rd, Chew
K
, . Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique
. Cancer
. 2001
;93
(4
):263
–8
.26.
Farras Roca
JA
, Tardivon
A
, Thibault
F
, El Khoury
C
, Alran
S
, Fourchotte
V
, . Diagnostic performance of ultrasound-guided fine-needle aspiration of nonpalpable breast lesions in a multidisciplinary setting: the institute curie’s experience
. Am J Clin Pathol
. 2017
;147
(6
):571
–9
.27.
Field
AS
, Schmitt
F
, Vielh
P
. IAC standardized reporting of breast fine-needle aspiration biopsy cytology
. Acta Cytol
. 2017
;61
(1
):3
–6
.28.
Schmitt
F
, Vielh
P
. Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer
. Histopathology
. 2015
;66
(2
):314
–5
.29.
Gibbons
CE
, Quinn
CM
, Gibbons
D
. Fine-needle aspiration biopsy management of the axilla in primary breast carcinoma
. Acta Cytol
. 2019
;63
(4
):314
–8
.30.
Boughey
JC
, Moriarty
JP
, Degnim
AC
, Gregg
MS
, Egginton
JS
, Long
KH
. Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer
. Ann Surg Oncol
. 2010
;17
(4
):953
–8
.31.
Modi
P
, Haren
O
, Jignasa
B
. FNAC as preoperative diagnostic tool for neoplastic and nonneoplastic breast lesions: a teaching hospital experience
. Indian J Med Res
. 2014
;4
:274
–8
.32.
Haobam
S
, Thiyam
U
, Sharma
DC
. Cytomorphologic Al study of breast lesions with sonomammographic correlation
. J Evol Med Dent
. 2015
;4
(81
):14137
–42
.33.
Nguansangiam
S
, Jesdapatarakul
S
, Tangjitgamol
S
. Accuracy of fine needle aspiration cytology from breast masses in Thailand
. Asian Pac J Cancer Prev
. 2009
;10
(4
):623
–6
.34.
Bajwa
R
, Tariq
Z
. Association of fine needle aspiration cytology with tumor size in palpable breast lesions
. Biomedica
. 2010
;26
:124
–9
.35.
Hoda
R
, Brachtel
E
. International Academy of Cytology-Yokohama System for reporting breast fine-needle aspiration biopsy cytopathology: a review of predictive values and risks of malignancy
. Acta Cytol
. 2019
;63
(4
):292
–301
.36.
Field
AS
, Zarka
MA
. Breast
. In: Field
AS
, Zarka
MA
, editors. Practical cytopathology: a diagnostic approach to fine needle aspiration biopsy
. Amsterdam
: Elsevier
; 2017
Chap. 5.37.
Madubogwu
CI
, Ukah
CO
, Anyanwu
S
, Chianakwana
GU
, Onyiaorah
IV
, Anyiam
D
. Sub-classification of breast masses by fine needle aspiration cytology
. Eur J Breast Health
. 2017
;13
(4
):194
–9
.38.
Singh
A
, Haritwal
A
, Murali
B
. Pattern of breast lumps and diagnostic accuracy of fine needle aspiration cytology; a hospital-based study from Pondicherry, India
. Internet J Pathol
. 2010
;11
(2
):1
–6
.39.
Muddegowda
PH
, Lingegowda
JB
, Kurpad
R
, Konapur
P
, Shivarudrappa
A
, Subramaniam
P
. The value of systematic pattern analysis in FNAC of breast lesions: 225 cases with cytohistological correlation
. J Cytol
. 2011
;28
(1
):13
–9
.40.
Challa
VR
, Yale Guru
BG
, Rangappa
P
, Deshmane
V
, Gayathri
DM
. Cytological and pathological correlation of fnac in assessing breast lumps and axillary lymph node swellings in a public sector hospital in India
. Patholog Res Int
. 2013
;2013
:695024
.41.
Singh
N
, Wells
CA
. Invited review: assessment of accuracy in breast cytology
. Cytopathology
. 2001
;12
(4
):211
–8
.42.
Sneige
N
. Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions
. Diagn Cytopathol
. 2004
;30
(3
):158
–65
.43.
al-Kaisi
N
. The spectrum of the “gray zone” in breast cytology. A review of 186 cases of atypical and suspicious cytology
. Acta Cytol
. 1994
;38
(6
):898
–908
.© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
You do not currently have access to this content.
